Skip to main content
    M

    Molina Healthcare Inc (MOH)

    Official site

    HEALTHCARE • HEALTHCARE PLANS • NYSE

    $233.25
    +23.76 (+11.34%)

    Market Cap: $10.89B

    Last updated: Nov 17, 2026 at 11:06 AM ET

    Molina Healthcare Inc (MOH) Earnings: Report Dates and Results

    Updated Oct 21, 2026. Results come from company earnings reports, and estimates are consensus analyst estimates.

    Molina Healthcare (MOH) is expected to report earnings on Feb 3, 2027. In the quarter ended Sep 30, 2026, Molina Healthcare reported EPS of $0.89, above the $0.72 estimate. It beat the EPS estimate in 4 of the last 8 quarters.

    Earnings

    Performance (10Y)

    Beat Rate
    79%(30/38)
    Avg Surprise
    -12.28%
    Streak
    3 Q

    Upcoming Estimates

    Reports Feb 3, 2027 (est.)Period ending Dec 31, 2026
    EPS Consensus$0.54
    Range$0.44 - $0.77
    21 analysts
    Revenue Consensus
    $12.01B
    Range$10.42B - $13.18B
    17 analysts
    Reports Apr 20, 2027 (est.)Period ending Mar 31, 2027
    EPS Consensus$3.01
    Range$2.07 - $3.81
    13 analysts
    EPS Revisions
    8
    3
    30d
    EPS Estimate DriftChange to current
    90d ago$3.05-1.2%
    60d ago$3.06-1.7%
    30d ago$3.07-2.0%
    7d ago$3.07-2.0%
    Current$3.01
    Revenue Consensus
    $11.76B
    Range$10.88B - $12.09B
    8 analysts

    Next Report

    MOH has an expected report date of Feb 3, 2027.

    MOH Earnings Call

    The latest MOH earnings call transcript on file is labeled 2026Q3.

    Read the 2026Q3 transcript

    Earnings History

    Of the 38 quarters below that had an estimate, MOH beat 30, missed 7 and matched 1. Revenue for the quarter ended Sep 30, 2026 was $11.08B, down 3.5% from $11.48B a year earlier.

    Quarter endedEPSEstimateRangeSurpriseResultYoYAnalystsRevisionsReportedRevenue
    Sep 30, 2026$0.89$0.72$0.69 - $1.68+23.61%Beat-51.6%180 up, 2 downOct 21, 2026$11.08B
    Jun 30, 2026$1.51$1.37$0.98 - $2.04+10.22%Beat-72.4%170 up, 3 downJul 22, 2026$10.87B
    Mar 31, 2026$2.35$1.91$1.02 - $3.14+23.04%Beat-61.3%160 up, 4 downApr 22, 2026$10.80B
    Dec 31, 2025-$2.75$0.50-$0.33 - $0.86-649.78%Miss-154.5%170 up, 2 downFeb 5, 2026$11.38B
    Sep 30, 2025$1.84$3.89$2.89 - $4.35-52.70%Miss-69.4%170 up, 1 downOct 22, 2025$11.48B
    Jun 30, 2025$5.48$5.53$5.11 - $6.11-0.90%Miss-6.5%130 up, 10 downJul 23, 2025$11.43B
    Mar 31, 2025$6.08$5.96$4.82 - $6.16+2.01%Beat+6.1%140 up, 2 downApr 23, 2025$11.15B
    Dec 31, 2024$5.05$5.88$5.43 - $6.15-14.12%Miss+15.3%131 up, 0 downFeb 5, 2025$10.50B
    Sep 30, 2024$6.01$5.94$5.70 - $6.18+1.18%Beat+19.0%140 up, 1 downOct 23, 2024$10.34B
    Jun 30, 2024$5.86$5.60$4.70 - $6.03+4.64%Beat+3.7%140 up, 1 downJul 24, 2024$9.88B
    Mar 31, 2024$5.73$5.64$5.21 - $6.36+1.60%Beat-1.4%151 up, 2 downApr 24, 2024$9.93B
    Dec 31, 2023$4.38$4.35$4.24 - $4.50+0.69%Beat+6.8%120 up, 0 downFeb 7, 2024$9.05B
    Sep 30, 2023$5.05$4.87$4.67 - $5.06+3.70%Beat+15.8%140 up, 0 downOct 25, 2023$8.55B
    Jun 30, 2023$5.65$5.13$4.55 - $5.71+10.14%Beat+24.2%164 up, 0 downJul 26, 2023$8.33B
    Mar 31, 2023$5.81$5.21$4.75 - $5.63+11.52%Beat+18.6%161 up, 0 downApr 26, 2023$8.15B
    Dec 31, 2022$4.10$4.02$3.93 - $4.34+1.99%Beat+42.4%162 up, 0 downFeb 8, 2023$8.22B
    Sep 30, 2022$4.36$4.23$4.00 - $4.34+3.07%Beat+54.1%142 up, 0 downOct 26, 2022$7.93B
    Jun 30, 2022$4.55$4.37$3.85 - $4.60+4.12%Beat+33.8%141 up, 1 downJul 27, 2022$8.05B
    Mar 31, 2022$4.90$4.68$4.45 - $5.17+4.70%Beat+10.4%142 up, 0 downApr 27, 2022$7.77B
    Dec 31, 2021$2.88$2.76$2.63 - $3.20+4.35%Beat-12.5%160 up, 0 downFeb 9, 2022$7.41B
    Sep 30, 2021$2.83$2.80$2.70 - $2.99+1.07%Beat-15.8%13N/AOct 27, 2021$7.04B
    Jun 30, 2021$3.40$3.40$3.09 - $3.950.00%In line-29.0%13N/AJul 28, 2021$6.80B
    Mar 31, 2021$4.44$3.71$3.15 - $4.41+19.68%Beat+47.0%12N/AApr 28, 2021$6.52B
    Dec 31, 2020$3.29$0.82$0.46 - $1.58+301.22%Beat+20.5%11N/AFeb 10, 2021$5.24B
    Sep 30, 2020$3.36$2.18$1.79 - $2.45+54.13%Beat+20.0%10N/AOct 28, 2020$5.02B
    Jun 30, 2020$4.79$4.95$2.95 - $6.21-3.23%Miss+54.0%11N/AJul 30, 2020$4.62B
    Mar 31, 2020$3.02$3.00$2.70 - $3.27+0.67%Beat-0.7%12N/AApr 30, 2020$4.55B
    Dec 31, 2019$2.73$2.65$2.55 - $2.76+3.02%Beat-11.1%15N/AFeb 10, 2020$4.27B
    Sep 30, 2019$2.80$2.73$2.64 - $2.84+2.56%Beat-5.7%16N/AOct 29, 2019$4.24B
    Jun 30, 2019$3.11$2.70$2.10 - $3.60+15.19%Beat+1.0%15N/AJul 30, 2019$4.19B
    Mar 31, 2019$3.04$2.45$2.05 - $2.80+24.08%Beat+128.6%15N/AApr 29, 2019$4.12B
    Dec 31, 2018$3.07$1.54$1.39 - $1.99+99.35%BeatN/A12N/AFeb 11, 2019$4.66B
    Sep 30, 2018$2.97$1.65$1.41 - $1.86+80.00%BeatN/A14N/AOct 31, 2018$4.70B
    Jun 30, 2018$3.08$1.09$0.85 - $1.41+182.57%BeatN/A15N/AJul 31, 2018$4.88B
    Mar 31, 2018$1.33$0.77$0.34 - $1.22+72.73%Beat-9.5%12N/AApr 30, 2018$4.65B
    Dec 31, 2017-$4.52$0.17-$0.63 - $0.94N/AN/AN/A14N/AFeb 12, 2018$4.95B
    Sep 30, 2017-$1.62$0.14-$0.74 - $0.88N/AN/A-290.6%10N/ANov 2, 2017$5.03B
    Jun 30, 2017-$4.01$0.87$0.70 - $1.08-560.92%Miss-698.5%14N/AAug 2, 2017$5.00B
    Mar 31, 2017$1.47$0.58N/A+153.45%Beat+188.2%N/AN/AMay 2, 2017$4.90B
    Dec 31, 2016-$1.54$0.75N/A-305.33%Miss-320.0%N/AN/AFeb 15, 2017$4.53B
    Last 40 quarters

    Annual EPS

    EPS for the fiscal year ended Dec 31, 2025 was $10.65, down 53.0% from the year before. It was $0.49 for the year ended Dec 31, 2016, the oldest of the 10 fiscal years shown.

    Fiscal year endedEPSChange
    Dec 31, 2025$10.65-53.0%
    Dec 31, 2024$22.65+8.4%
    Dec 31, 2023$20.89+16.6%
    Dec 31, 2022$17.91+32.2%
    Dec 31, 2021$13.55-6.3%
    Dec 31, 2020$14.46+23.8%
    Dec 31, 2019$11.68+11.8%
    Dec 31, 2018$10.45N/A
    Dec 31, 2017-$8.68-1871.4%
    Dec 31, 2016$0.49N/A

    Earnings Calls

    The 8 most recent earnings calls are listed below; the latest, 2026Q3 for the period ended Sep 30, 2026, runs about 8,000 words across 17 speakers.

    CallPeriod endingWordsSpeakersTranscript
    2026Q3Sep 30, 20268,03517
    2026Q2Jun 30, 20268,09417
    2026Q1Mar 31, 20268,42919
    2025Q4Dec 31, 20259,17316
    2025Q3Sep 30, 20258,97017
    2025Q2Jun 30, 202510,10316
    2025Q1Mar 31, 20257,74017
    2024Q4Dec 31, 20249,21913

    2026Q3 Earnings Call

    Opening remarks

    Jeff Geyer Investor Relations The conference is now being recorded. The conference has not been initiated. You will be placed on hold until a chairperson arrives. Good morning, and welcome to Molina Healthcare's third quarter 2026 earnings call. Joining me today are Molina's President and CEO, Joe Zubretsky, and our CFO, Mark Keim. A press release announcing our third quarter 2026 earnings was distributed after the market closed yesterday and is available on our investor relations website. Shortly after the conclusion of this call, a replay will be available for 30 days. The numbers to access the replay are in the earnings release. For those of you who listen to the rebroadcast of this presentation, we remind you that all of the remarks are made as of today, Thursday, October 22nd, 2026, and have not been updated subsequent to the initial earnings call. On this call, we will refer to certain non-GAAP measures. A reconciliation of these measures with the most directly comparable GAAP measures can be found in the earnings release. During the call, we will be making certain forward-looking statements, including, but not limited to, statements regarding our 2026 guidance and expected segment performance, rates and medical cost trend, the implementation and performance of the Florida CMS contract, our preliminary 2027 premium and earnings outlook and related building blocks, Marketplace pricing, footprint, and program integrity initiatives, Medicare Stars and duals performance, Medicaid work requirements and reverifications and associated medical costs, our RFP awards and implementation timing, our long-term financial targets, and the amount and realization of embedded earnings. Listeners are cautioned that all of our forward-looking statements are subject to certain risks and uncertainties that could cause our actual results to differ materially from our current expectations. We advise listeners to review the risk factors discussed in our Form 10-K annual report filed with the SEC, as well as our risk factors listed in our Form 10-Q and Form 8-K filings with the SEC. After the completion of our prepared remarks, we will open the call to take your questions. I will now turn the call over to our Chief Executive Officer, Joe Zubretsky. Joe?

    Joe Zubretsky CEO Thank you, Jeff, and good morning. Today, I will discuss several topics: our third quarter results, our reaffirmed full year 2026 guidance, and our preliminary 2027 premium and earnings outlook. Let me start with our third quarter performance. Last night, we reported adjusted earnings per share of $0.89 on $10.5 billion of premium revenue. Our 92.9% consolidated MCR reflects solid operating performance as we continue to navigate a challenging medical cost environment. We produced a 0.6% adjusted pre-tax margin in the quarter and 1.1% year to date.

    Frequently Asked Questions About MOH

    When is Molina Healthcare's next earnings date?

    Molina Healthcare's next earnings report is expected for Feb 3, 2027.

    Did MOH beat earnings estimates last quarter?

    Yes. Molina Healthcare reported EPS of $0.89 for the quarter ended Sep 30, 2026, above the $0.72 estimate, a 23.61% surprise.

    What EPS do analysts expect from MOH next quarter?

    The consensus EPS estimate for Molina Healthcare for the quarter ending Dec 31, 2026 is $0.54 from 21 analysts, with estimates from $0.44 to $0.77.

    How often does MOH beat earnings estimates?

    Molina Healthcare beat the EPS estimate in 4 of the last 8 quarters, with an average surprise of -82.33%.